Glucagon-like peptide-1 (GLP-1) receptor agonists show promise for treating fatty liver disease, particularly in patients with type 2 diabetes or obesity
Most studies show little to no change in diastolic pressure
Rapid weight loss without adequate protein intake, resistance training, mobility work, and structured follow-up may increase the risk of lean tissue loss, tendon overload, frailty, and downstream musculoskeletal complications
A 2022 study published in the Journal of Pharmaceutical Sciences found that reduced L-glutathione stored at room temperature (25C) lost 40% potency within 90 days
keep the reconstituted solution refrigerated and use it within a few weeks
Recalls & Warnings June 22, 2023 FDA Warns Warrior Labz for Selling Products with Steroid-Like Substances and Prescription Drugs On June 12, 2023, the FDA issued a warning letter to Warrior Labz SARMS following inspection of the companys website and social media, which found that the company sold the following products labeled as containing steroid-like substances known as selective androgen receptor modulators